Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method
| العنوان: | Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method |
|---|---|
| المؤلفون: | Hogervorst, Frans B. L., Nederlof, Petra M., Gille, Johan J. P., McElgunn, Cathal J., Grippeling, Maartje, Pruntel, Roelof, Regnerus, Rein, van Welsem, Tibor, van Spaendonk, Resie, Menko, Fred H., Kluijt, Irma, Dommering, Charlotte, Verhoef, Senno, Schouten, Jan P., van't Veer, Laura J., Pals, Gerard |
| المساهمون: | Human genetics, CCA - Cancer biology and immunology, Human Genetics |
| المصدر: | Cancer Research, 63(7), 1449-53. American Association for Cancer Research Inc. Hogervorst, F B L, Nederlof, P M, Gille, J J P, McElgunn, C J, Grippeling, M, Pruntel, R, Regnerus, R, van Welsem, T, van Spaendonk, R, Menko, F H, Kluijt, I, Dommering, C, Verhoef, S, Schouten, J P, van't Veer, L J & Pals, G 2003, ' Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method ', Cancer Research, vol. 63, no. 7, pp. 1449-53 . Cancer research, 63(7), 1449-1453. American Association for Cancer Research Inc. |
| سنة النشر: | 2003 |
| مصطلحات موضوعية: | endocrine system diseases, skin and connective tissue diseases |
| الوصف: | We applied a novel method to detect single or multiple exon deletions and amplifications in the BRCA1 gene. The test, called multiplex ligation-dependent probe amplification (MLPA), uses probes designed to hybridize adjacently to the target sequence. After ligation, the joined probes are amplified and quantified. Our two diagnostic laboratories have tested in the recent years 805 families by conventional PCR-based techniques, and found 116 BRCA1 and 28 BRCA2 mutation-positive families. Using MLPA, we have tested the remaining 661 noninformative breast cancer families and identified five distinct BRCA1 germ-line mutations in five families: a deletion of exon 8, a deletion of exons 20-22, a duplication of exon 13 and exons 21-23, respectively, and a triplication, encompassing exons 17-19. Genomic deletions of BRCA1 constitute a substantial fraction of mutations in Dutch breast cancer families. If MLPA had been included in our initial BRCA1 testing, 33 families with a deletion or duplication would have been identified, representing 27% of the total 121 BRCA1 mutation-positive families. The MLPA test for BRCA1 ensures a sensitive and comprehensive high-throughput screening test for genomic rearrangement and can easily be implemented in the molecular analysis of BRCA1. |
| اللغة: | English |
| تدمد: | 0008-5472 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c4550809006aa5968ccd31648db88cdc https://research.vumc.nl/en/publications/fb3d5be9-99cd-45d6-8e48-bb2647401021 |
| Rights: | RESTRICTED |
| رقم الانضمام: | edsair.dedup.wf.001..c4550809006aa5968ccd31648db88cdc |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 00085472 |
|---|